Link between credibility and statements of model uses
Posted: Mon Jun 10, 2013 1:35 pm
We can all envision a particular model being judged credible when put to particular uses in one biomedical research, development, or clinical context, but not when put to different uses in another context.
To stimulate discussion, I suggest that a prerequisite for discussion of a model’s credibility is having clear practical (application focused) and technical text stating commitments covering uses envisioned by the model’s engineers. I suggest that a prerequisite for actually building credibility for that model is evidence in support of those commitments.
I see model credibility involving connected quality issues: the quality (and credibility) of the M&S results depend on the quality of the executable, which depends on the quality of the model, which depends on the quality of the use cases.
From a technical perspective, all models of interest to the Committee will be characterizable as engineered, executable, software (SW) devices. Thus, I see model credibility having at least two, somewhat independent, separately addressable components: the device and the model, which can be independent of the device that implements.
I suggest that a prerequisite to building model credibility is having documentation supporting credibility of the executable. Software device engineering begins with identification of device use cases. In the larger healthcare M&S context, the quality of SW device use case statements will depend on identification and descriptions of the variety of model use cases, immediate and envisioned.
Note: my expectation is that the Committee’s credibility discussions will necessarily focus on the reuse (and improvement) of computational models and their components, both within a particular research group as well as by others.
If the Committee agrees with the above position, then clear statements of best practices can be developed.
To stimulate discussion, I suggest that a prerequisite for discussion of a model’s credibility is having clear practical (application focused) and technical text stating commitments covering uses envisioned by the model’s engineers. I suggest that a prerequisite for actually building credibility for that model is evidence in support of those commitments.
I see model credibility involving connected quality issues: the quality (and credibility) of the M&S results depend on the quality of the executable, which depends on the quality of the model, which depends on the quality of the use cases.
From a technical perspective, all models of interest to the Committee will be characterizable as engineered, executable, software (SW) devices. Thus, I see model credibility having at least two, somewhat independent, separately addressable components: the device and the model, which can be independent of the device that implements.
I suggest that a prerequisite to building model credibility is having documentation supporting credibility of the executable. Software device engineering begins with identification of device use cases. In the larger healthcare M&S context, the quality of SW device use case statements will depend on identification and descriptions of the variety of model use cases, immediate and envisioned.
Note: my expectation is that the Committee’s credibility discussions will necessarily focus on the reuse (and improvement) of computational models and their components, both within a particular research group as well as by others.
If the Committee agrees with the above position, then clear statements of best practices can be developed.